Strand Therapeutics

Co-op, Analytical Development

Strand Therapeutics  •  $28/hr  •  Boston, MA (Onsite)  •  5 days ago
Apply
AI can make mistakes so check important info. Chat history is never stored.
49
AI Success™

Job Description

Strand Therapeutics is a clinical stage biotechnology company utilizing synthetic biology to genetically program mRNA to deliver truly revolutionary immunotherapies to patients.

Building on the idea of creating smart therapies based on Boolean logic circuits, Strand was started by biological engineers working together at MIT who were seeking to apply the concept of the emerging field of mRNA therapeutics. Strand's technology is therapeutic-area and mRNA modality agnostic where therapeutic proteins are encoded onto modified, self-replicating, or circular mRNA backbones which in turn are programmed with cell-specific sensors and circuits.

Today, Strand has established three platforms with one clinical stage asset and several programs in preclinical development as well as early discovery. Our lead program, STX-001, is currently being evaluated in a phase 1 clinical trial for solid tumors. Our corporate headquarters is located in the Fenway district of Boston, Massachusetts.

Become the next standout single strand!

Strand is looking for people who have the enthusiasm and motivation to be a highly contributing member of a small but extremely productive team. This opportunity will offer the employee the ability to work in a matrix-based environment and be a part of the future strategy of the company.

We are looking for a Co-op, Analytical Development to join the Analytical Development team at Strand Therapeutics. The incoming co-op will work with the Analytical Development teams to help advance our analytical capabilities by executing on various experiments using techniques such as UPLC and LC/MS. The candidate will be expected to work in an innovative, fast-paced, and collaborative biotech environment.

Primary Responsibilities:

  • Assisting in development and execution of chromatography-based mRNA/LNP analytical methods.
  • Using various statistical tools to analyze and independently draw conclusions about data.
  • Analytically supporting the screening, optimization, and scale-up efforts in mRNA and LNP Process Development.
  • Working across diverse areas to support the group's development activities in a fast-paced and collaborative environment.

Qualifications:

  • On track to graduate with a B.S. or M.S. in Biochemistry, Chemical Engineering, Molecular Biology, Bioengineering, Molecular Medicine, Genetics or related field. Experience in the biotechnology space is a plus.
  • mRNA working experience is strongly preferred, but not a requirement.
  • Basic knowledge of varying liquid chromatography modes such as RP, RP-IP, AEX, SEC etc. for biologics is desirable.
  • Familiarity with process development, and/or regulatory aspects of mRNA/LNP products would be a plus.
  • Ability to follow standard operating procedures, make careful observations, maintain clear and complete records of lab work.‪
  • Strong collaboration and inter-personal skills. Ability to present scientific context, experimental set up, data interpretation, and big-picture conclusions to a diverse audience.

Strand Therapeutics is an equal opportunity employer. We do not discriminate on the basis of race, color, gender, gender identity, sexual orientation, age, religion, national or ethnic origin, disability, protected veteran status or any other basis protected by applicable law. Strand does not accept unsolicited resumes from any source other than directly from candidates.

Job Type: Co-op

Hourly Rate: $25 - $28 / hour

Strand Therapeutics

About Strand Therapeutics

Strand was founded by biological engineers working together at the Massachusetts Institute of Technology (MIT). Building on the idea of creating smart therapies capable of making sophisticated decisions, they sought to apply this concept to the emerging field of mRNA therapeutics. This area was previously untapped by traditional synthetic biology, leading us to build our very own mRNA programming language, creating the world’s first platform for mRNA smart therapies.

Strand’s mRNA programming technology promises to make mRNA therapies safer and more effective by programming the location, timing, and intensity of therapeutic protein expression inside a patient’s body via mRNA-encoded logic circuits. These circuits have the ability to implement cell-type specific expressions by sensing and classifying the unique mRNA expression signatures of cells and control the dosage of protein expression through responses to exogenously administered small molecules.

Industry
Biotech & Life Sciences
Company Size
51-200 employees
Headquarters
Boston, Massachusetts
Year Founded
2017
Social Media